Fluvoxamine and long COVID-19; a new role for sigma-1 receptor (S1R) agonists.
Mol Psychiatry
; 27(9): 3562, 2022 09.
Article
in En
| MEDLINE
| ID: mdl-35388182
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Receptors, sigma
/
COVID-19
Limits:
Humans
Language:
En
Journal:
Mol Psychiatry
Journal subject:
BIOLOGIA MOLECULAR
/
PSIQUIATRIA
Year:
2022
Document type:
Article
Affiliation country:
Irán